Search Results 631-640 of 4307 for 2024sweden
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. Indication for use: "The Svelte DES is indicated for improving coronary luminal diameter in patients with symptomatic heart disease, ...
Repletion of testosterone (T) in older men drives Growth Hormone secretion after its aromatization to estradiol (E2) by potentiating endogenous GH drive.
The purpose of this study is to investigate the safety and effectiveness of FE 999049 compared to placebo in women aged 18-34 years old. Participation ...
Cabozantinib-s-malate and sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known ...
A Randomized, Placebo-controlled, Double-blind, Multi-center Phase 2/3 Trial To Assess Efficacy And Safety Of Octreotide Subcutaneous Depot (CAM2029) In ...
About this study. The purpose of this study is to determine if elevations in oxidative stress, as measured by oxidation-reduction potential (ORP), ...
About this study. The purpose of this study is to evaluate the safety and effectiveness of a moderate hypofractionation regimen of proton beam therapy with ...
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Overview.
About this study. This partially randomized phase I/II trial studies the side effects and best dose of sapanisertib and to see how well it works compared to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!